Boehringer Ingelheim, a top 20 biopharma company, has partnered with Veeva Systems to standardize customer data across more than 100 countries using Veeva OpenData and Veeva Network. This strategic move enhances healthcare professional (HCP) engagement and lays the groundwork for advanced AI applications, reinforcing Boehringer’s commitment to commercial excellence.
Boehringer Ingelheim adopts Veeva OpenData and Network for global data standardization.
Solutions provide accurate customer data for effective HCP engagement in 100+ countries.
Unified data strategy supports seamless migration to Veeva Vault CRM.
Veeva’s tools enable cross-team collaboration and operational efficiency.
Standardized data sets the foundation for scaling AI-driven use cases.
Partnership strengthens Boehringer’s focus on patient-centric outcomes.
Boehringer Ingelheim’s adoption of Veeva OpenData and Veeva Network enables its teams to access accurate and comprehensive customer reference data, improving engagement with healthcare professionals. By providing a unified customer view, these solutions ensure field and brand teams deliver relevant, impactful interactions. “Extending our trusted partnership with Veeva by adopting globally harmonized data will strengthen customer engagement and pave the way for future AI use cases,” said Uday Bose, head of human pharma global customer experience excellence and business steering at Boehringer Ingelheim. “Veeva OpenData and Veeva Network will empower our field and brand teams with a unified customer view to drive impactful and coordinated interactions focused on patient outcomes.”
By consolidating its data strategy into a single, comprehensive solution, Boehringer Ingelheim simplifies data management and enhances operational efficiency. Veeva OpenData ensures fast access to consistent, high-quality customer data across global teams and regions, fostering seamless collaboration. The integration of Veeva’s connected software and data also streamlines Boehringer’s migration to Veeva Vault CRM, leveraging native integrations with OpenData and Network. This unified approach reduces complexity and supports Boehringer’s goal of delivering patient-focused outcomes through efficient commercial execution.
Veeva OpenData and Network provide a scalable data foundation that positions Boehringer Ingelheim for future AI-driven innovations. Accurate customer data enables advanced analytics and personalized engagement strategies, critical for staying competitive in the biopharma industry. “Boehringer’s forward-looking strategy of connected software and data sets the foundation for continued commercial excellence and future AI success,” said Kilian Weiss, senior vice president, Data Cloud International at Veeva. “Together, Vault CRM, OpenData, and Network deliver an integrated solution that connects data, enhances HCP engagement, and drives AI innovation at scale.”
Boehringer Ingelheim’s partnership with Veeva Systems, a leader in cloud software for the life sciences industry, strengthens its ability to deliver personalized HCP interactions and prepare for AI-driven advancements. With Veeva OpenData as part of the Veeva Data Cloud and Veeva Network integrated into the Vault CRM Suite, Boehringer is well-equipped to drive commercial agility and innovation, supporting its goal of up to 25 new treatment launches by 2030. The finance card above shows Veeva’s stock performance (NYSE: VEEV, current price $286.215), reflecting its strong market position as it continues to expand its influence in biopharma.
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.